| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1021759171 |
| P356 | DOI | 10.1038/NRM3810 |
| P698 | PubMed publication ID | 24854788 |
| P5875 | ResearchGate publication ID | 262577917 |
| P50 | author | Chris Dobson | Q1982431 |
| Michele Vendruscolo | Q28322492 | ||
| P2093 | author name string | Tuomas P J Knowles | |
| P2860 | cites work | Secondary structure of alpha-synuclein oligomers: characterization by raman and atomic force microscopy | Q81515488 |
| Intrinsically unstructured proteins and their functions | Q22061731 | ||
| Alzheimer's Disease | Q22248111 | ||
| Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease | Q22251067 | ||
| A Three-Dimensional Model of the Myoglobin Molecule Obtained by X-Ray Analysis | Q22251297 | ||
| The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction | Q24292709 | ||
| The Protein Data Bank | Q24515306 | ||
| Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation | Q24530946 | ||
| Structure of the cross-beta spine of amyloid-like fibrils | Q24548308 | ||
| pE-DB: a database of structural ensembles of intrinsically disordered and of unfolded proteins | Q24567790 | ||
| Cell mechanics and the cytoskeleton | Q24601132 | ||
| Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells | Q24607640 | ||
| Prions, protein homeostasis, and phenotypic diversity | Q24610666 | ||
| Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease | Q24612662 | ||
| Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks | Q24622558 | ||
| Prions | Q24633319 | ||
| Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging | Q24643933 | ||
| Misfolded proteins partition between two distinct quality control compartments | Q24651093 | ||
| ApoE promotes the proteolytic degradation of Abeta | Q24651102 | ||
| Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease | Q24670696 | ||
| Mechanism of prion propagation: amyloid growth occurs by monomer addition | Q24793082 | ||
| Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders | Q26850298 | ||
| Mechanisms of protein seeding in neurodegenerative diseases | Q26994962 | ||
| Self-propagation of pathogenic protein aggregates in neurodegenerative diseases | Q26996441 | ||
| Widespread protein aggregation as an inherent part of aging in C. elegans | Q27323997 | ||
| Benzoxazoles as transthyretin amyloid fibril inhibitors: synthesis, evaluation, and mechanism of action | Q27641464 | ||
| Atomic structures of amyloid cross-beta spines reveal varied steric zippers | Q27644644 | ||
| Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core | Q27650075 | ||
| Atomic structure and hierarchical assembly of a cross- amyloid fibril | Q27676898 | ||
| Structure of an intermediate state in protein folding and aggregation | Q27678629 | ||
| Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade | Q27679360 | ||
| Mutation in the alpha-synuclein gene identified in families with Parkinson's disease | Q27860459 | ||
| Alpha-synuclein in Lewy bodies | Q27860680 | ||
| Autophagy fights disease through cellular self-digestion | Q27860902 | ||
| The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 | ||
| PolyQ proteins interfere with nuclear degradation of cytosolic proteins by sequestering the Sis1p chaperone | Q27937491 | ||
| Long unfolded linkers facilitate membrane protein import through the nuclear pore complex. | Q27940107 | ||
| Protein misfolding, functional amyloid, and human disease | Q28131732 | ||
| Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide | Q28131750 | ||
| Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo | Q28131779 | ||
| Adapting proteostasis for disease intervention | Q28131818 | ||
| Review: history of the amyloid fibril | Q28143393 | ||
| Protein misfolding, evolution and disease | Q28143452 | ||
| Protein folding and misfolding | Q28235199 | ||
| Principles that govern the folding of protein chains | Q28236872 | ||
| A general model of prion strains and their pathogenicity | Q28256770 | ||
| The roles of intracellular protein-degradation pathways in neurodegeneration | Q28269322 | ||
| Protein misfolding and disease: from the test tube to the organism | Q28269867 | ||
| Protein aggregation and neurodegenerative disease | Q28273600 | ||
| Nucleated conformational conversion and the replication of conformational information by a prion determinant | Q33915141 | ||
| Protein homeostasis and aging: The importance of exquisite quality control | Q33925901 | ||
| The protofilament structure of insulin amyloid fibrils | Q34034361 | ||
| Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease | Q34055098 | ||
| An analytical solution to the kinetics of breakable filament assembly | Q34087905 | ||
| Cellular strategies for controlling protein aggregation | Q34143451 | ||
| Characterization of the oligomeric states of insulin in self-assembly and amyloid fibril formation by mass spectrometry | Q34173720 | ||
| Rationalization of the effects of mutations on peptide and protein aggregation rates. | Q34222395 | ||
| Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution | Q34225700 | ||
| Direct observation of the interconversion of normal and toxic forms of α-synuclein | Q34277399 | ||
| Protein chemistry. In the footsteps of alchemists | Q34323404 | ||
| Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism | Q34346440 | ||
| Molecular chaperone functions in protein folding and proteostasis | Q34349321 | ||
| Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins | Q28281645 | ||
| From Levinthal to pathways to funnels | Q28300934 | ||
| A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR | Q28387681 | ||
| Sequestration of the Abeta peptide prevents toxicity and promotes degradation in vivo | Q28473205 | ||
| Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease | Q28539839 | ||
| Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway | Q28854318 | ||
| A specific amyloid-beta protein assembly in the brain impairs memory | Q28854597 | ||
| The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-β(1-40) peptide | Q28854601 | ||
| Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins | Q29547856 | ||
| Impairment of the ubiquitin-proteasome system by protein aggregation | Q29614556 | ||
| Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease | Q29614881 | ||
| The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics | Q29614972 | ||
| Importing mitochondrial proteins: machineries and mechanisms | Q29616477 | ||
| Translocation of proteins into mitochondria | Q29616478 | ||
| Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases | Q29616535 | ||
| The structure and function of G-protein-coupled receptors | Q29616792 | ||
| A Drosophila model of Parkinson's disease | Q29617052 | ||
| 3D structure of Alzheimer's amyloid-beta(1-42) fibrils | Q29617475 | ||
| Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators | Q29618401 | ||
| Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders | Q29619537 | ||
| Amyloid fibril formation by an SH3 domain | Q30176202 | ||
| Understanding protein non-folding. | Q30385084 | ||
| Theory of protein folding: the energy landscape perspective | Q30428743 | ||
| Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques | Q30486499 | ||
| Observation of spatial propagation of amyloid assembly from single nuclei | Q30504078 | ||
| Single molecule characterization of the interactions between amyloid-β peptides and the membranes of hippocampal cells | Q30533868 | ||
| Nature disfavors sequences of alternating polar and non-polar amino acids: implications for amyloidogenesis | Q30841228 | ||
| Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein | Q31151074 | ||
| Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection | Q33204250 | ||
| Structural reorganisation and potential toxicity of oligomeric species formed during the assembly of amyloid fibrils | Q33302932 | ||
| A generic mechanism of emergence of amyloid protofilaments from disordered oligomeric aggregates | Q33384411 | ||
| Functional amyloids as natural storage of peptide hormones in pituitary secretory granules | Q33834886 | ||
| Clusterin is a secreted mammalian chaperone | Q33850022 | ||
| Elongated oligomers in beta2-microglobulin amyloid assembly revealed by ion mobility spectrometry-mass spectrometry | Q33859337 | ||
| The secretases: enzymes with therapeutic potential in Alzheimer disease | Q33887222 | ||
| In silico study of amyloid beta-protein folding and oligomerization | Q34374164 | ||
| A potential decline in life expectancy in the United States in the 21st century | Q34405620 | ||
| Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases | Q34422461 | ||
| Structural insights into a yeast prion illuminate nucleation and strain diversity | Q34425023 | ||
| Common core structure of amyloid fibrils by synchrotron X-ray diffraction. | Q34444888 | ||
| The importance of sequence diversity in the aggregation and evolution of proteins | Q34474861 | ||
| Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses. | Q34477195 | ||
| Progressive disruption of cellular protein folding in models of polyglutamine diseases. | Q34493281 | ||
| In vivo demonstration that alpha-synuclein oligomers are toxic | Q34652122 | ||
| Role of intermolecular forces in defining material properties of protein nanofibrils | Q34728278 | ||
| Amyloid formation by globular proteins under native conditions | Q34905853 | ||
| Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning | Q34932593 | ||
| The "Correctly Folded" state of proteins: is it a metastable state? | Q35030203 | ||
| New opportunities for an ancient material | Q35106828 | ||
| Characterization of the nanoscale properties of individual amyloid fibrils | Q35127474 | ||
| Solid-state NMR studies of amyloid fibril structure | Q35327629 | ||
| Protein solubility and protein homeostasis: a generic view of protein misfolding disorders | Q35578436 | ||
| Salt-induced detour through compact regions of the protein folding landscape | Q35708354 | ||
| Kinetics and thermodynamics of amyloid formation from direct measurements of fluctuations in fibril mass | Q35840489 | ||
| Probing the origins, diagnosis and treatment of amyloid diseases using antibodies | Q35958377 | ||
| Proteomic analysis of age-dependent changes in protein solubility identifies genes that modulate lifespan | Q36220305 | ||
| Drosophila as a model for human neurodegenerative disease | Q36312196 | ||
| Designing conditions for in vitro formation of amyloid protofilaments and fibrils | Q36445068 | ||
| Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses | Q36605276 | ||
| A century-old debate on protein aggregation and neurodegeneration enters the clinic | Q36628151 | ||
| Paired beta-sheet structure of an Abeta(1-40) amyloid fibril revealed by electron microscopy | Q36677152 | ||
| Functional amyloid--from bacteria to humans. | Q36782474 | ||
| Influence of specific HSP70 domains on fibril formation of the yeast prion protein Ure2 | Q36801199 | ||
| Superresolution imaging of amyloid fibrils with binding-activated probes | Q37025846 | ||
| Proteomic identification of novel proteins associated with Lewy bodies | Q37146740 | ||
| Plug-based microfluidics with defined surface chemistry to miniaturize and control aggregation of amyloidogenic peptides | Q37175261 | ||
| Cell-to-cell transmission of non-prion protein aggregates. | Q37200740 | ||
| Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction | Q37301074 | ||
| Widespread aggregation and neurodegenerative diseases are associated with supersaturated proteins | Q37442810 | ||
| The transcellular spread of cytosolic amyloids, prions, and prionoids | Q37671889 | ||
| Protein folding on the ribosome studied using NMR spectroscopy. | Q37710489 | ||
| Nanomechanics of functional and pathological amyloid materials. | Q37908990 | ||
| Inhibition of amyloid formation | Q37975817 | ||
| A molecular history of the amyloidoses | Q37982894 | ||
| From macroscopic measurements to microscopic mechanisms of protein aggregation | Q37992391 | ||
| The amyloid state of proteins in human diseases | Q37994283 | ||
| On the possible amyloid origin of protein folds | Q38006259 | ||
| Intrinsically disordered proteins and novel strategies for drug discovery | Q38007557 | ||
| Gene expression profiling in human neurodegenerative disease | Q38034387 | ||
| Treatment strategies targeting amyloid β-protein | Q38040990 | ||
| Microbial manipulation of the amyloid fold | Q38056340 | ||
| Chemical kinetics for drug discovery to combat protein aggregation diseases | Q38190285 | ||
| Differential scales of protein quality control | Q38200251 | ||
| A model for the role of short self-assembled peptides in the very early stages of the origin of life | Q38324302 | ||
| The seeds of neurodegeneration: prion-like spreading in ALS | Q39247056 | ||
| In situ measurements of the formation and morphology of intracellular β-amyloid fibrils by super-resolution fluorescence imaging | Q39500047 | ||
| Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions | Q39610788 | ||
| The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation | Q39665703 | ||
| A causative link between the structure of aberrant protein oligomers and their toxicity. | Q39750915 | ||
| The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways | Q41728317 | ||
| The X-ray interpretation of denaturation and the structure of the seed globulins | Q41896564 | ||
| ANS binding reveals common features of cytotoxic amyloid species | Q43021800 | ||
| Single point mutations induce a switch in the molecular mechanism of the aggregation of the Alzheimer's disease associated Aβ42 peptide | Q43523290 | ||
| Structural biology: Protein self-assembly intermediates | Q43921711 | ||
| Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice | Q44182586 | ||
| α-Synuclein Is Degraded by Both Autophagy and the Proteasome | Q44420467 | ||
| Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation | Q44769438 | ||
| Prediction of aggregation-prone regions in structured proteins | Q45335883 | ||
| The physical basis of how prion conformations determine strain phenotypes | Q46092862 | ||
| Prefibrillar amyloid aggregates could be generic toxins in higher organisms. | Q48456315 | ||
| Absolute correlation between lag time and growth rate in the spontaneous formation of several amyloid-like aggregates and fibrils. | Q51927728 | ||
| Selenium-enhanced electron microscopic imaging of different aggregate forms of a segment of the amyloid β peptide in cells. | Q53159868 | ||
| Protein Folding: A Perspective from Theory and Experiment. | Q54308010 | ||
| Alzheimer's disease | Q55880664 | ||
| Enhancement of Protein Crystal Nucleation by Critical Density Fluctuations | Q56932074 | ||
| Beyond the prion principle | Q57083618 | ||
| Twisting transition between crystalline and fibrillar phases of aggregated peptides | Q57184016 | ||
| Metastability of Native Proteins and the Phenomenon of Amyloid Formation | Q57227118 | ||
| Life on the edge: a link between gene expression levels and aggregation rates of human proteins | Q57227222 | ||
| Mapping Long-Range Interactions in α-Synuclein using Spin-Label NMR and Ensemble Molecular Dynamics Simulations | Q57976902 | ||
| Spatial Propagation of Protein Polymerization | Q57986454 | ||
| Prediction of the Absolute Aggregation Rates of Amyloidogenic Polypeptide Chains | Q58374785 | ||
| Insights into phase transition kinetics from colloid science | Q59085657 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 384-396 | |
| P577 | publication date | 2014-06-01 | |
| P1433 | published in | Nature Reviews Molecular Cell Biology | Q1573120 |
| P1476 | title | The amyloid state and its association with protein misfolding diseases. | |
| P478 | volume | 15 |
| Q52600981 | 3D structure determination of amyloid fibrils using solid-state NMR spectroscopy. |
| Q90132988 | A Cell- and Tissue-Specific Weakness of the Protein Homeostasis System Underlies Brain Vulnerability to Protein Aggregation |
| Q37134269 | A Decentralized Approach to the Formulation of Hypotheses: A Hierarchical Structural Model for a Prion Self-Assembled System |
| Q46274343 | A Free Energy Barrier Caused by the Refolding of an Oligomeric Intermediate Controls the Lag Time of Amyloid Formation by hIAPP. |
| Q41015741 | A HaloTag Anchored Ruler for Week-Long Studies of Protein Dynamics |
| Q36754686 | A High Affinity Red Fluorescence and Colorimetric Probe for Amyloid β Aggregates |
| Q40710845 | A Metabolic Shift toward Pentose Phosphate Pathway Is Necessary for Amyloid Fibril- and Phorbol 12-Myristate 13-Acetate-induced Neutrophil Extracellular Trap (NET) Formation |
| Q36121846 | A New Folding Kinetic Mechanism for Human Transthyretin and the Influence of the Amyloidogenic V30M Mutation. |
| Q38634630 | A Plasma Cell Dyscrasia Presenting as Amyloid Cardiomyopathy and Autonomic Dysfunction in a Healthy Patient |
| Q42532927 | A Population Shift between Sparsely Populated Folding Intermediates Determines Amyloidogenicity |
| Q55032468 | A Rationally Designed Hsp70 Variant Rescues the Aggregation-Associated Toxicity of Human IAPP in Cultured Pancreatic Islet β-Cells. |
| Q45091172 | A Tetramer Derived from Islet Amyloid Polypeptide. |
| Q30852309 | A comprehensive database of verified experimental data on protein folding kinetics |
| Q37004163 | A current pharmacologic agent versus the promise of next generation therapeutics to ameliorate protein misfolding and/or aggregation diseases |
| Q46002678 | A dominant-negative mutant inhibits multiple prion variants through a common mechanism. |
| Q51074523 | A fine-tuned composition of protein nanofibrils yields an upgraded functionality of displayed antibody binding domains. |
| Q35492910 | A flexible approach to assess fluorescence decay functions in complex energy transfer systems |
| Q38852916 | A glass menagerie of low complexity sequences. |
| Q54977494 | A hydrophobic low complexity region regulates the aggregation of the yeast pyruvate kinase Cdc19 into amyloid-like aggregates in vitro. |
| Q36772997 | A mathematical model of the dynamics of prion aggregates with chaperone-mediated fragmentation |
| Q91651765 | A metastable subproteome underlies inclusion formation in muscle proteinopathies |
| Q43026275 | A minichaperone-based fusion system for producing insoluble proteins in soluble stable forms |
| Q36129561 | A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers |
| Q35146724 | A multi-pathway perspective on protein aggregation: implications for control of the rate and extent of amyloid formation |
| Q35715535 | A native interactor scaffolds and stabilizes toxic ATAXIN-1 oligomers in SCA1. |
| Q30838501 | A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity |
| Q59794682 | A near atomic-scale view at the composition of amyloid-beta fibrils by atom probe tomography |
| Q57787227 | A new era for understanding amyloid structures and disease |
| Q35137541 | A new mechanism links preamyloid oligomer formation in the myocyte stress response associated with atrial fibrillation |
| Q50125039 | A peptide-display protein scaffold to facilitate single molecule force studies of aggregation-prone peptides. |
| Q42365992 | A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer's disease. |
| Q99564822 | A rationally designed bicyclic peptide remodels Aβ42 aggregation in vitro and reduces its toxicity in a worm model of Alzheimer's disease |
| Q34447530 | A relationship between the transient structure in the monomeric state and the aggregation propensities of α-synuclein and β-synuclein |
| Q33583650 | A resorcinarene for inhibition of Aβ fibrillation |
| Q27330000 | A switchable self-assembling and disassembling chiral system based on a porphyrin-substituted phenylalanine-phenylalanine motif |
| Q47205509 | A systematic atlas of chaperome deregulation topologies across the human cancer landscape |
| Q36866261 | A transcriptional signature of Alzheimer's disease is associated with a metastable subproteome at risk for aggregation |
| Q41627906 | A β-hairpin-binding protein for three different disease-related amyloidogenic proteins |
| Q37367600 | AFM-Based Single Molecule Techniques: Unraveling the Amyloid Pathogenic Species. |
| Q47152913 | Absolute Quantification of Amyloid Propagons by Digital Microfluidics |
| Q42373056 | Adaptation to Stressors by Systemic Protein Amyloidogenesis. |
| Q40813650 | Aggregation of Beta-Amyloid Peptides Proximal to Zwitterionic Lipid Bilayers |
| Q31170430 | Aggregation prone regions in human proteome: Insights from large-scale data analyses |
| Q36484002 | Allosteric stabilization of the amyloid-β peptide hairpin by the fluctuating N-terminal |
| Q38771037 | Alternative stable conformation capable of protein misinteraction links tRNA synthetase to peripheral neuropathy |
| Q36139907 | Amino Acid Proximities in Two Sup35 Prion Strains Revealed by Chemical Cross-linking. |
| Q38773864 | Amphiphilic copolymers reduce aggregation of unfolded lysozyme more effectively than polyethylene glycol |
| Q42697451 | AmyPro: a database of proteins with validated amyloidogenic regions |
| Q92651158 | Amyloid Oligomers, Protofibrils and Fibrils |
| Q58621641 | Amyloid assembly and disassembly |
| Q28649959 | Amyloid domains in the cell nucleus controlled by nucleoskeletal protein lamin B1 reveal a new pathway of mercury neurotoxicity |
| Q90673210 | Amyloid fibril structure of α-synuclein determined by cryo-electron microscopy |
| Q42092379 | Amyloid formation by human carboxypeptidase D transthyretin-like domain under physiological conditions |
| Q39385143 | Amyloid plaques beyond Aβ: a survey of the diverse modulators of amyloid aggregation |
| Q41469538 | Amyloid single-cell cytotoxicity assays by nanomotion detection |
| Q89619262 | Amyloid structure determination in RELION-3.1. |
| Q28384947 | Amyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's disease |
| Q89511279 | Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro |
| Q90248863 | Amyloid-like Behavior of Site-Specifically Citrullinated Myelin Oligodendrocyte Protein (MOG) Peptide Fragments inside EBV-Infected B-Cells Influences Their Cytotoxicity and Autoimmunogenicity |
| Q41008649 | Amyloid-like Fibrils from an α-Helical Transmembrane Protein |
| Q36026994 | Amyloids assemble as part of recognizable structures during oogenesis in Xenopus. |
| Q93014137 | Amyloids in Site-Specific Autoimmune Reactions and Inflammatory Responses |
| Q36593553 | An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease |
| Q42688779 | An in vivo platform for identifying inhibitors of protein aggregation |
| Q35754381 | Analysis of Amyloid in Medullary Thyroid Carcinoma by Mass Spectrometry-Based Proteomic Analysis |
| Q38853212 | Analysis of Toxic Amyloid Fibril Interactions at Natively Derived Membranes by Ellipsometry |
| Q61810442 | Anomalous Dense Liquid Condensates Host the Nucleation of Tumor Suppressor p53 Fibrils |
| Q88965411 | Antibodies towards Tyrosine Amyloid-Like Fibrils Allow Toxicity Modulation and Cellular Imaging of the Assemblies |
| Q91774849 | Antioxidant Berberine-Derivative Inhibits Multifaceted Amyloid Toxicity |
| Q51812569 | Appearance of annular ring-like intermediates during amyloid fibril formation from human serum albumin. |
| Q38481462 | Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer's Disease? |
| Q93039143 | Arginine π-stacking drives binding to fibrils of the Alzheimer protein Tau |
| Q57785286 | Assays for Light Chain Amyloidosis Formation and Cytotoxicity |
| Q38985724 | Assembly and regulation of ASC specks |
| Q41637828 | Assembly of Peptides Derived from β-Sheet Regions of β-Amyloid |
| Q93047126 | Association of Transfusion With Risks of Dementia or Alzheimer's Disease: A Population-Based Cohort Study |
| Q41921037 | Atomic Scale Structural Studies of Macromolecular Assemblies by Solid-state Nuclear Magnetic Resonance Spectroscopy. |
| Q64099425 | Atomic force microscopy for single molecule characterisation of protein aggregation |
| Q92757035 | Atomic structure of PI3-kinase SH3 amyloid fibrils by cryo-electron microscopy |
| Q52333975 | Atomic structures of FUS LC domain segments reveal bases for reversible amyloid fibril formation. |
| Q57909514 | Atomic structures of TDP-43 LCD segments and insights into reversible or pathogenic aggregation |
| Q64897272 | Atomic-level evidence for packing and positional amyloid polymorphism by segment from TDP-43 RRM2 |
| Q48224711 | Aβ plaque-selective NIR fluorescence probe to differentiate Alzheimer's disease from tauopathies. |
| Q36382326 | BODIPY-Based Fluorescent Probes for Sensing Protein Surface-Hydrophobicity. |
| Q89703505 | Bifunctional ligand design for modulating mutant p53 aggregation in cancer |
| Q41074727 | Binding affinity of amyloid oligomers to cellular membranes is a generic indicator of cellular dysfunction in protein misfolding diseases |
| Q90642082 | Biochemical and biophysical characterisation of immunoglobulin free light chains derived from an initially unbiased population of patients with light chain disease |
| Q48135831 | Biocompatible and blood-brain barrier permeable carbon dots for inhibition of Aβ fibrillation and toxicity, and BACE1 activity. |
| Q47722422 | Biophysical Aspects of Alzheimer's Disease: Implications for Pharmaceutical Sciences : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla |
| Q38578280 | Biophysical approaches for the study of interactions between molecular chaperones and protein aggregates |
| Q96129239 | Biophysical studies of protein misfolding and aggregation in in vivo models of Alzheimer's and Parkinson's diseases |
| Q55518824 | CalFitter: a web server for analysis of protein thermal denaturation data. |
| Q39162492 | Cellular Regulation of Amyloid Formation in Aging and Disease |
| Q38715103 | Cellular mechanism of fibril formation from serum amyloid A1 protein. |
| Q35285839 | Chaperoned amyloid proteins for immune manipulation: α-Synuclein/Hsp70 shifts immunity toward a modulatory phenotype |
| Q53839637 | Chaperones convert the energy from ATP into the nonequilibrium stabilization of native proteins. |
| Q26782943 | Chaperones in Neurodegeneration |
| Q96608940 | Characterization of amyloid β fibril formation under microgravity conditions |
| Q38901646 | Chiral recognition in amyloid fiber growth |
| Q57986255 | Cholesterol catalyses Aβ42 aggregation through a heterogeneous nucleation pathway in the presence of lipid membranes |
| Q89452358 | Cholesterol: A Key in the Pathogenesis of Alzheimer's Disease |
| Q45980426 | Clinical characteristics of laryngeal versus nonlaryngeal amyloidosis. |
| Q97537574 | Clustering of human prion protein and α-synuclein oligomers requires the prion protein N-terminus |
| Q46424825 | Coaggregation of κ-Casein and β-Lactoglobulin Produces Morphologically Distinct Amyloid Fibrils |
| Q41637849 | Coassembly of Peptides Derived from β-Sheet Regions of β-Amyloid |
| Q47449871 | Cofibrillization of Pathogenic and Functional Amyloid Proteins with Gold Nanoparticles against Amyloidogenesis. |
| Q92241558 | Collagen I Weakly Interacts with the β-Sheets of β2-Microglobulin and Enhances Conformational Exchange To Induce Amyloid Formation |
| Q38679540 | Compound heterozygous FXN mutations and clinical outcome in friedreich ataxia |
| Q59613574 | Computational Insight into the Effect of Natural Compounds on the Destabilization of Preformed Amyloid-β(1⁻40) Fibrils |
| Q92028272 | Concentration-dependent polymorphism of insulin amyloid fibrils |
| Q52323065 | Conformational flexibility within the nascent polypeptide-associated complex enables its interactions with structurally diverse client proteins. |
| Q38856199 | Conformational selection in amyloid-based immunotherapy: Survey of crystal structures of antibody-amyloid complexes |
| Q36139365 | Conformational switch of polyglutamine-expanded huntingtin into benign aggregates leads to neuroprotective effect |
| Q53196220 | Contact between the β1 and β2 Segments of α-Synuclein that Inhibits Amyloid Formation. |
| Q42380173 | Controlling the bioactivity of a peptide hormone in vivo by reversible self-assembly |
| Q48314753 | Covalent Tethering and Residues with Bulky Hydrophobic Side Chains Enable Self-Assembly of Distinct Amyloid Structures |
| Q34752964 | Crucial role of nonspecific interactions in amyloid nucleation. |
| Q28081678 | Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways |
| Q59326994 | Cyclic undecapeptide Cyclosporin A mediated inhibition of amyloid synthesis: Implications in alleviation of amyloid induced neurotoxicity |
| Q39039735 | DNA repair in the trinucleotide repeat disorders |
| Q96953982 | Deep learning methods in protein structure prediction |
| Q53833658 | Dementia and vagotomy in Taiwan: a population-based cohort study. |
| Q40144733 | Designed α-sheet peptides suppress amyloid formation in Staphylococcus aureus biofilms |
| Q54257505 | Detection of amyloid fibrils in Parkinson's disease using plasmonic chirality. |
| Q38965470 | Development of a high affinity Affibody-derived protein against amyloid β-peptide for future Alzheimer's disease therapy |
| Q90041021 | Different Synergy in Amyloids and Biologically Active Forms of Proteins |
| Q38702791 | Different amyloid aggregation of smooth muscles titin in vitro. |
| Q48361211 | Differential effects of silver and iron oxide nanoparticles on IAPP amyloid aggregation |
| Q40960261 | Direct Observation of the Intrinsic Backbone Torsional Mobility of Disordered Proteins. |
| Q98303515 | Direct measurement of lipid membrane disruption connects kinetics and toxicity of Aβ42 aggregation |
| Q47826829 | Direct observation of oligomerization by single molecule fluorescence reveals a multi-step aggregation mechanism for the yeast prion protein Ure2. |
| Q64054589 | Direct observation of prion protein oligomer formation reveals an aggregation mechanism with multiple conformationally distinct species |
| Q64114173 | Directing curli polymerization with DNA origami nucleators |
| Q26796603 | Disaggregases, molecular chaperones that resolubilize protein aggregates |
| Q40784268 | Disaggregation of Amylin Aggregate by Novel Conformationally Restricted Aminobenzoic Acid containing α/β and α/γ Hybrid Peptidomimetics |
| Q47663701 | Disease-associated protein seeding suggests a dissociation between misfolded protein accumulation and neurodegeneration in prion disease |
| Q51080542 | Disentangling a Bad Reputation: Changing Perceptions of Amyloids. |
| Q94560636 | Disentangling the Amyloid Pathways: A Mechanistic Approach to Etiology |
| Q30375859 | DisoMCS: Accurately Predicting Protein Intrinsically Disordered Regions Using a Multi-Class Conservative Score Approach. |
| Q64251024 | Distinct Binding Dynamics, Sites and Interactions of Fullerene and Fullerenols with Amyloid-β Peptides Revealed by Molecular Dynamics Simulations |
| Q36182814 | Distinct Prion Domain Sequences Ensure Efficient Amyloid Propagation by Promoting Chaperone Binding or Processing In Vivo |
| Q30661910 | Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions |
| Q36049159 | Distinct transcriptional responses elicited by unfolded nuclear or cytoplasmic protein in mammalian cells |
| Q92135614 | Diverse Misfolded Conformational Strains and Cross-seeding of Misfolded Proteins Implicated in Neurodegenerative Diseases |
| Q41101237 | Documentation of an Imperative To Improve Methods for Predicting Membrane Protein Stability |
| Q35781398 | Druggability of Intrinsically Disordered Proteins |
| Q56534985 | Dual roles for ATP in the regulation of phase separated protein aggregates in oocyte nucleoli |
| Q87917741 | Dynamic protein folding at the surface of stimuli-responsive peptide fibrils |
| Q64910306 | Dynamical Oligomerisation of Histidine Rich Intrinsically Disordered ProteinS Is Regulated through Zinc-Histidine Interactions. |
| Q90660404 | Dynamics of oligomer and amyloid fibril formation by yeast prion Sup35 observed by high-speed atomic force microscopy |
| Q91874866 | Dynamics of oligomer populations formed during the aggregation of Alzheimer's Aβ42 peptide |
| Q51112827 | Dynamics of the conformational transitions during the dimerization of an intrinsically disordered peptide: a case study on the human islet amyloid polypeptide fragment. |
| Q30375302 | EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication. |
| Q55638585 | EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication. |
| Q45939560 | EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. |
| Q92942047 | Effect of Terminal Modifications on the Adsorption and Assembly of hIAPP(20-29) |
| Q33732704 | Effects of Protein Corona on IAPP Amyloid Aggregation, Fibril Remodelling, and Cytotoxicity |
| Q47299318 | Effects of force fields on the conformational and dynamic properties of amyloid β(1-40) dimer explored by replica exchange molecular dynamics simulations |
| Q47579033 | Electrostatic lipid-protein interactions sequester the curli amyloid fold on the lipopolysaccharide membrane surface |
| Q58566190 | Elucidating the multi-targeted anti-amyloid activity and enhanced islet amyloid polypeptide binding of -wrapins |
| Q42369036 | Endoplasmic Reticulum Proteostasis Influences the Oligomeric State of an Amyloidogenic Protein Secreted from Mammalian Cells |
| Q37173197 | Energy landscapes of a mechanical prion and their implications for the molecular mechanism of long-term memory |
| Q35558791 | Energy landscapes of functional proteins are inherently risky |
| Q28083809 | Engineering enhanced protein disaggregases for neurodegenerative disease |
| Q93089175 | Enhancement of the Anti-Aggregation Activity of a Molecular Chaperone Using a Rationally Designed Post-Translational Modification |
| Q40482939 | Epigallocatechin Gallate Remodels Overexpressed Functional Amyloids in Pseudomonas aeruginosa and Increases Biofilm Susceptibility to Antibiotic Treatment. |
| Q28066862 | Epigenetic inheritance of proteostasis and ageing |
| Q46539191 | Estimation of the lag time in a subsequent monomer addition model for fibril elongation |
| Q42328729 | Evidence for Intramolecular Antiparallel Beta-Sheet Structure in Alpha-Synuclein Fibrils from a Combination of Two-Dimensional Infrared Spectroscopy and Atomic Force Microscopy. |
| Q92801744 | Exploring the potential of deep-blue autofluorescence for monitoring amyloid fibril formation and dissociation |
| Q38515389 | Exploring the structure and formation mechanism of amyloid fibrils by Raman spectroscopy: a review |
| Q92441264 | Expression of the amyloid-β peptide in a single pair of C. elegans sensory neurons modulates the associated behavioural response |
| Q42619969 | Extension of the generic amyloid hypothesis to nonproteinaceous metabolite assemblies |
| Q42653482 | Extracellular vesicles from human pancreatic islets suppress human islet amyloid polypeptide amyloid formation |
| Q90347873 | FAIM Is a Non-redundant Defender of Cellular Viability in the Face of Heat and Oxidative Stress and Interferes With Accumulation of Stress-Induced Protein Aggregates |
| Q46259884 | Factors affecting the physical stability (aggregation) of peptide therapeutics |
| Q64124342 | Femtosecond Hydration Map of Intrinsically Disordered α-Synuclein |
| Q42033500 | Few Ramachandran Angle Changes Provide Interaction Strength Increase in Aβ42 versus Aβ40 Amyloid Fibrils |
| Q47838176 | Fibril structure of amyloid-β(1-42) by cryo-electron microscopy |
| Q45951781 | Fluorotryptophan Incorporation Modulates the Structure and Stability of Transthyretin in a Site-Specific Manner. |
| Q55421516 | Folding mechanisms steer the amyloid fibril formation propensity of highly homologous proteins. |
| Q92831796 | Formation of biological condensates via phase separation: Characteristics, analytical methods, and physiological implications |
| Q92070015 | Functional Amyloids and their Possible Influence on Alzheimer Disease |
| Q42517320 | Functional Role of Cyclin-Dependent Kinase 5 in the Regulation of Melanogenesis and Epidermal Structure |
| Q64060780 | Functional Segments on Intrinsically Disordered Regions in Disease-Related Proteins |
| Q47404503 | Functional amyloids: interrelationship with other amyloids and therapeutic assessment to treat neurodegenerative diseases. |
| Q98906756 | Gallic acid oxidation products alter the formation pathway of insulin amyloid fibrils |
| Q37126036 | Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting |
| Q90240391 | Generation of the configurational ensemble of an intrinsically disordered protein from unbiased molecular dynamics simulation |
| Q39141476 | Genetics of Synucleinopathies |
| Q47161219 | Geometrical frustration yields fiber formation in self-assembly |
| Q37167845 | Getting to the core of prion superstructural variability. |
| Q30393668 | Glycation in Demetalated Superoxide Dismutase 1 Prevents Amyloid Aggregation and Produces Cytotoxic Ages Adducts |
| Q57798818 | Graphene quantum dots against human IAPP aggregation and toxicity in vivo |
| Q57021977 | Heat shock promotes inclusion body formation of mutant huntingtin (mHtt) and alleviates mHtt-induced transcription factor dysfunction |
| Q38815318 | Heat shock proteins as potential targets for protective strategies in neurodegeneration |
| Q51270448 | Helical Folding Competing with Unfolded Aggregation in Phenylene Ethynylene Foldamers. |
| Q41062902 | Heterologous prion-forming proteins interact to cross-seed aggregation in Saccharomyces cerevisiae |
| Q36217985 | High resolution structural characterization of Aβ42 amyloid fibrils by magic angle spinning NMR. |
| Q92643434 | High-yield Production of Amyloid-β Peptide Enabled by a Customized Spider Silk Domain |
| Q87910173 | Highly Disordered Amyloid-β Monomer Probed by Single-Molecule FRET and MD Simulation |
| Q89473464 | How and Why to Build a Mathematical Model: A Case Study Using Prion Aggregation |
| Q41525997 | Hsp78 (78 kDa Heat Shock Protein), a Representative AAA Family Member Found in the Mitochondrial Matrix of Saccharomyces cerevisiae. |
| Q53820041 | Hsp90 shapes protein and RNA evolution to balance trade-offs between protein stability and aggregation. |
| Q50055253 | Hspb7 is a cardioprotective chaperone facilitating sarcomeric proteostasis. |
| Q35753373 | Human Hsp70 Disaggregase Reverses Parkinson's-Linked α-Synuclein Amyloid Fibrils |
| Q35115100 | Hypertension is associated with preamyloid oligomers in human atrium: a missing link in atrial pathophysiology? |
| Q47563579 | Identification and characterization of antibodies elicited by human cystatin C fragment. |
| Q57986235 | Identification and nanomechanical characterization of the fundamental single-strand protofilaments of amyloid α-synuclein fibrils |
| Q30384397 | Identification of fibrillogenic regions in human triosephosphate isomerase. |
| Q47449222 | Imaging Aβ(1-42) fibril elongation reveals strongly polarised growth and growth incompetent states |
| Q36127853 | Imaging stress |
| Q54224883 | Impact of membrane curvature on amyloid aggregation. |
| Q39431937 | Implications of peptide assemblies in amyloid diseases |
| Q91266367 | In Silico Evidence That Protein Unfolding is a Precursor of Protein Aggregation |
| Q49344570 | In Situ Structure of Neuronal C9orf72 Poly-GA Aggregates Reveals Proteasome Recruitment. |
| Q90370110 | In silico prediction of novel residues involved in amyloid primary nucleation of human I56T and D67H lysozyme |
| Q41497184 | In vitro aggregating β-lactamase-polyQ chimeras do not induce toxic effects in an in vivo Caenorhabditis elegans model. |
| Q90321544 | Increase in soluble protein oligomers triggers the innate immune system promoting inflammation and vascular dysfunction in the pathogenesis of sepsis |
| Q64231004 | Infinite Assembly of Folded Proteins in Evolution, Disease, and Engineering |
| Q38497247 | Information flow and protein dynamics: the interplay between nuclear magnetic resonance spectroscopy and molecular dynamics simulations |
| Q55276020 | Inhibition of Protein Aggregation by Several Antioxidants. |
| Q87935135 | Inhibition of amyloid beta fibril formation by monomeric human transthyretin |
| Q92797090 | Inhibition of amyloid beta toxicity in zebrafish with a chaperone-gold nanoparticle dual strategy |
| Q38686092 | Inhibition of amyloid oligomerization into different supramolecular architectures by small molecules: mechanistic insights and design rules |
| Q46271724 | Inhibition of curli assembly and Escherichia coli biofilm formation by the human systemic amyloid precursor transthyretin |
| Q57840236 | Inhibitory effect of hydrophobic fullerenes on the β-sheet-rich oligomers of a hydrophilic GNNQQNY peptide revealed by atomistic simulations |
| Q46859332 | Initial condition of stochastic self-assembly |
| Q48273790 | Injection of insulin amyloid fibrils in the hippocampus of male Wistar rats: report on memory impairment and formation of amyloid plaques |
| Q93051676 | Inorganic polyphosphate, a multifunctional polyanionic protein scaffold |
| Q50650754 | Insights into the variability of nucleated amyloid polymerization by a minimalistic model of stochastic protein assembly. |
| Q39045135 | Insulin Formulation Characterization-the Thioflavin T Assays |
| Q27300783 | Interaction Potentials of Anisotropic Nanocrystals from the Trajectory Sampling of Particle Motion using in Situ Liquid Phase Transmission Electron Microscopy |
| Q39236779 | Interactions of pathological proteins in neurodegenerative diseases |
| Q92724345 | Interference with Amyloid-β Nucleation by Transient Ligand Interaction |
| Q50318104 | Intramolecular diffusion controls aggregation of the PAPf39 peptide. |
| Q39066009 | Intraneuronal protein aggregation as a trigger for inflammation and neurodegeneration in the aging brain |
| Q36569512 | Intrinsic and membrane-facilitated α-synuclein oligomerization revealed by label-free detection through solid-state nanopores |
| Q64067678 | Intrinsically aggregation-prone proteins form amyloid-like aggregates and contribute to tissue aging in |
| Q40962797 | Intrinsically disordered energy landscapes |
| Q41611227 | Investigating heart-specific toxicity of amyloidogenic immunoglobulin light chains: A lesson from C. elegans |
| Q92948723 | Investigating in Vitro Amyloid Peptide 1-42 Aggregation: Impact of Higher Molecular Weight Stable Adducts |
| Q64062984 | Investigating the Formation of Structural Elements in Proteins Using Local Sequence-Dependent Information and a Heuristic Search Algorithm |
| Q61813463 | Investigating the Molecular Basis of the Aggregation Propensity of the Pathological D76N Mutant of Beta-2 Microglobulin: Role of the Denatured State |
| Q100490791 | Iodine staining as a useful probe for distinguishing insulin amyloid polymorphs |
| Q47834508 | Islet Amyloid Polypeptide Promotes Amyloid-beta Aggregation by Binding-induced Helix-unfolding of the Amyloidogenic Core |
| Q90384233 | Kinetic Transition in Amyloid Assembly as a Screening Assay for Oligomer-Selective Dyes |
| Q57078194 | Kinetic analysis of the multistep aggregation pathway of human transthyretin |
| Q39867365 | Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation |
| Q41930338 | Kinetic constraints on self-assembly into closed supramolecular structures. |
| Q57370500 | Kinetic theory of protein filament growth: Self-consistent methods and perturbative techniques |
| Q64122008 | Large-scale all-atom molecular dynamics alanine-scanning of IAPP octapeptides provides insights into the molecular determinants of amyloidogenicity |
| Q48175105 | Layers of structure and function in protein aggregation |
| Q46173279 | Lessons learned from protein aggregation: toward technological and biomedical applications. |
| Q37277893 | Linking in domain-swapped protein dimers |
| Q41065976 | Lipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation |
| Q52679530 | Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease. |
| Q38603046 | Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular co-morbidities. |
| Q113878572 | Liquid–liquid phase separation underpins the formation of replication factories in rotaviruses |
| Q60922145 | Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology |
| Q91588167 | Long Noncoding RNAs and Stress Response in the Nucleolus |
| Q31027853 | Long range Trp-Trp interaction initiates the folding pathway of a pro-angiogenic β-hairpin peptide |
| Q94554106 | Long-range Regulation of Partially Folded Amyloidogenic Peptides |
| Q55044856 | Looking at the Disordered Proteins through the Computational Microscope. |
| Q30400256 | MOAG-4 promotes the aggregation of α-synuclein by competing with self-protective electrostatic interactions |
| Q48251902 | Mammalian amyloidogenic proteins promote prion nucleation in yeast. |
| Q40310052 | Mapping the Broad Structural and Mechanical Properties of Amyloid Fibrils. |
| Q64119705 | Matter over mind: Liquid phase separation and neurodegeneration |
| Q55251949 | Measurement of Tau Filament Fragmentation Provides Insights into Prion-like Spreading. |
| Q26797492 | Mechanisms of amyloid formation revealed by solution NMR |
| Q64068092 | Melting Down Protein Stability: PAPS Synthase 2 in Patients and in a Cellular Environment |
| Q41666582 | Membrane-Accelerated Amyloid-β Aggregation and Formation of Cross-β Sheets. |
| Q64239976 | Mesencephalic astrocyte-derived neurotrophic factor (MANF) protects against Aβ toxicity via attenuating Aβ-induced endoplasmic reticulum stress |
| Q26779046 | Metazoan Hsp70-based protein disaggregases: emergence and mechanisms |
| Q38669148 | Methods of probing the interactions between small molecules and disordered proteins |
| Q57986198 | Microfluidic deposition for resolving single-molecule protein architecture and heterogeneity |
| Q38673966 | Mining databases for protein aggregation: a review |
| Q36271072 | Misfolded opsin mutants display elevated β-sheet structure |
| Q58123355 | Mitigating Human IAPP Amyloidogenesis In Vivo with Chiral Silica Nanoribbons |
| Q47206608 | Model membrane size-dependent amyloidogenesis of Alzheimer's amyloid-β peptides |
| Q26739032 | Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity |
| Q40506178 | Modeling the Aggregation Propensity and Toxicity of Amyloid-β Variants. |
| Q41808931 | Modulation of electrostatic interactions to reveal a reaction network unifying the aggregation behaviour of the Aβ42 peptide and its variants |
| Q57587073 | Modulation of human IAPP fibrillation: cosolutes, crowders and chaperones |
| Q48138690 | Molecular Role of Ca2+ and Hard Divalent Metal Cations on Accelerated Fibrillation and Interfibrillar Aggregation of α-Synuclein |
| Q52375207 | Molecular basis for diversification of yeast prion strain conformation. |
| Q64882394 | Molecular insights into the surface-catalyzed secondary nucleation of amyloid-β40 (Aβ40) by the peptide fragment Aβ16–22. |
| Q42394229 | Molecular tweezers for lysine and arginine - powerful inhibitors of pathologic protein aggregation |
| Q49425578 | Monomer Dynamics of Alzheimer Peptides and Kinetic Control of Early Aggregation in Alzheimer's Disease. |
| Q41579457 | Monomer-dependent secondary nucleation in amyloid formation |
| Q36569893 | Monomeric Aβ(1-40) and Aβ(1-42) Peptides in Solution Adopt Very Similar Ramachandran Map Distributions That Closely Resemble Random Coil |
| Q41256308 | Monomeric and fibrillar α-synuclein exert opposite effects on the catalytic cycle that promotes the proliferation of Aβ42 aggregates |
| Q90379922 | More than Just a Phase: Prions at the Crossroads of Epigenetic Inheritance and Evolutionary Change |
| Q91729861 | Mortality of Alzheimer's Disease Patients: A 10-Year Follow-up Pilot Study in Shanghai |
| Q47999160 | Multimodal imaging Gd-nanoparticles functionalized with Pittsburgh compound B or a nanobody for amyloid plaques targeting |
| Q41677793 | Multisite aggregation of p53 and implications for drug rescue |
| Q34538864 | Mutations associated with familial Parkinson's disease alter the initiation and amplification steps of α-synuclein aggregation |
| Q96952294 | NSs amyloid formation is associated with the virulence of Rift Valley fever virus in mice |
| Q91241962 | Nanoplasmonic mid-infrared biosensor for in vitro protein secondary structure detection |
| Q53498139 | Nanopore analysis of amyloid fibrils formed by lysozyme aggregation. |
| Q90385471 | Nanoscale dynamic chemical, biological sensor material designs for control monitoring and early detection of advanced diseases |
| Q57142491 | Nanoscale inhibition of polymorphic and ambidextrous IAPP amyloid aggregation with small molecules |
| Q37157361 | Nanoscale studies link amyloid maturity with polyglutamine diseases onset. |
| Q38733078 | Natural product-based amyloid inhibitors. |
| Q38615267 | Natural supramolecular protein assemblies. |
| Q27011744 | Neurodegenerative diseases: expanding the prion concept |
| Q37199192 | Neutron Scattering Studies of the Interplay of Amyloid β Peptide(1-40) and An Anionic Lipid 1,2-dimyristoyl-sn-glycero-3-phosphoglycerol |
| Q35548333 | New insight into the structure and function of Hfq C-terminus |
| Q53698735 | No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases. |
| Q42166297 | Non-covalent S···O interactions control conformation in a scaffold that disrupts islet amyloid polypeptide fibrillation |
| Q64897446 | Noncovalent, Electrostatic Interactions Induce Positively Cooperative Binding of Small Molecules to Alzheimer's and Parkinson's Disease-Related Amyloids. |
| Q38603497 | Not All β-Sheets Are the Same: Amyloid Infrared Spectra, Transition Dipole Strengths, and Couplings Investigated by 2D IR Spectroscopy |
| Q64061136 | Novel Mannitol-Based Small Molecules for Inhibiting Aggregation of α-Synuclein Amyloids in Parkinson's Disease |
| Q59797123 | Novel iatrogenic amyloidosis caused by peptide drug liraglutide: a clinical mimic of AL amyloidosis |
| Q38719390 | Nucleation and growth of a bacterial functional amyloid at single-fiber resolution |
| Q51595806 | Nucleation of Amyloid Oligomers by RepA-WH1-Prionoid-Functionalized Gold Nanorods. |
| Q94522117 | Nucleation seed size determines amyloid clearance and establishes a barrier to prion appearance in yeast |
| Q91869139 | Nucleolar Sequestration: Remodeling Nucleoli Into Amyloid Bodies |
| Q57986225 | Oligomer Diversity during the Aggregation of the Repeat Region of Tau |
| Q97528472 | On the Conformational Dynamics of β-Amyloid Forming Peptides: A Computational Perspective |
| Q50568235 | On the kinetics of body versus end evaporation and addition of supramolecular polymers. |
| Q35684777 | On the lack of polymorphism in Aβ-peptide aggregates derived from patient brains |
| Q54958087 | On-chip measurements of protein unfolding from direct observations of micron-scale diffusion. |
| Q47629109 | One-Pot Synthesis of Thermoresponsive Amyloidogenic Peptide-Polymer Conjugates via Thio-Bromo "Click" Reaction of RAFT Polymers. |
| Q93115560 | Optimal control strategies for inhibition of protein aggregation |
| Q64324277 | Organization of Amino Acids into Layered Supramolecular Secondary Structures |
| Q34661497 | Orientation of aromatic residues in amyloid cores: structural insights into prion fiber diversity |
| Q99616831 | Osmolytes dynamically regulate mutant Huntingtin aggregation and CREB function in Huntington's disease cell models |
| Q47133897 | Outer membrane protein folding from an energy landscape perspective |
| Q98563342 | Ozone: a natural bioactive molecule with antioxidant property as potential new strategy in aging and in neurodegenerative disorders |
| Q28076932 | PMEL Amyloid Fibril Formation: The Bright Steps of Pigmentation |
| Q36583195 | Pancreatic β-Cell Membrane Fluidity and Toxicity Induced by Human Islet Amyloid Polypeptide Species. |
| Q51201173 | Partially-deuterated samples of HET-s(218-289) fibrils: assignment and deuterium isotope effect. |
| Q41657000 | Peptide sequences converting polyglutamine into a prion in yeast. |
| Q47432395 | Peptidoglycan-Sensing Receptors Trigger the Formation of Functional Amyloids of the Adaptor Protein Imd to Initiate Drosophila NF-κB Signaling. |
| Q35558034 | Personalized biochemistry and biophysics |
| Q33847755 | Phage display and kinetic selection of antibodies that specifically inhibit amyloid self-replication |
| Q95940310 | Phagocytic glia are obligatory intermediates in transmission of mutant huntingtin aggregates across neuronal synapses |
| Q48379137 | Phosphorylation at Ser8 as an Intrinsic Regulatory Switch to Regulate the Morphologies and Structures of Alzheimer's 40-residue β-Amyloid (Aβ40) Fibrils |
| Q40249589 | Phosphorylation modifies the molecular stability of β-amyloid deposits. |
| Q54111585 | Phosphorylation-Mediated Clearance of Amyloid-like Assemblies in Meiosis. |
| Q90874267 | Physical PEGylation to Prevent Insulin Fibrillation |
| Q56930960 | Physical determinants of the self-replication of protein fibrils |
| Q35826191 | Polymorphism Analysis Reveals Reduced Negative Selection and Elevated Rate of Insertions and Deletions in Intrinsically Disordered Protein Regions |
| Q89595346 | Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains |
| Q46407929 | Potential Artifacts in Sample Preparation Methods Used for Imaging Amyloid Oligomers and Protofibrils due to Surface-Mediated Fibril Formation. |
| Q38806392 | Potential applications of stress solutes from extremophiles in protein folding diseases and healthcare |
| Q46236939 | Pre-aggregation kinetics and intermediates of α-synuclein monitored by the ESIPT probe 7MFE. |
| Q48046659 | Predicting low-temperature free energy landscapes with flat-histogram Monte Carlo methods |
| Q28546984 | Prediction of Peptide and Protein Propensity for Amyloid Formation |
| Q27307839 | Prion Aggregates Are Recruited to the Insoluble Protein Deposit (IPOD) via Myosin 2-Based Vesicular Transport |
| Q26797972 | Prion-induced neurotoxicity: Possible role for cell cycle activity and DNA damage response |
| Q38313208 | Prion-like features of misfolded Aβ and tau aggregates |
| Q35889023 | Prion-like transmission of neuronal huntingtin aggregates to phagocytic glia in the Drosophila brain |
| Q91730805 | Probing the Origin of the Toxicity of Oligomeric Aggregates of α-Synuclein with Antibodies |
| Q92694063 | Prolines Affect the Nucleation Phase of Amyloid Fibrillation Reaction; Mutational Analysis of Human Stefin B |
| Q31039692 | Protein Ensembles: How Does Nature Harness Thermodynamic Fluctuations for Life? The Diverse Functional Roles of Conformational Ensembles in the Cell |
| Q26801512 | Protein Folding and Mechanisms of Proteostasis |
| Q39097864 | Protein aggregation, misfolding and consequential human neurodegenerative diseases. |
| Q90683378 | Protein assembly systems in natural and synthetic biology |
| Q33913554 | Protein homeostasis of a metastable subproteome associated with Alzheimer's disease |
| Q90840565 | Protein misassembly and aggregation as potential convergence points for non-genetic causes of chronic mental illness |
| Q37697832 | Protein misfolding in neurodegenerative diseases: implications and strategies |
| Q39124557 | Proteins Containing Expanded Polyglutamine Tracts and Neurodegenerative Disease |
| Q26739684 | Proteins behaving badly. Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting |
| Q47982938 | Proteins evolve on the edge of supramolecular self-assembly |
| Q92355998 | Proteome-wide observation of the phenomenon of life on the edge of solubility |
| Q39022241 | Proteopathic Strains and the Heterogeneity of Neurodegenerative Diseases. |
| Q89446379 | Quantifying Nucleation In Vivo Reveals the Physical Basis of Prion-like Phase Behavior |
| Q40116497 | Quantitative analysis of intrinsic and extrinsic factors in the aggregation mechanism of Alzheimer-associated Aβ-peptide |
| Q38680217 | Quantitative computational models of molecular self-assembly in systems biology |
| Q36694459 | Quantitative thermophoretic study of disease-related protein aggregates |
| Q35961236 | Rational design of antibodies targeting specific epitopes within intrinsically disordered proteins |
| Q41085989 | Rational design of mutations that change the aggregation rate of a protein while maintaining its native structure and stability |
| Q34995740 | Reactive γ-ketoaldehydes promote protein misfolding and preamyloid oligomer formation in rapidly-activated atrial cells |
| Q88914624 | Real-Time In Situ Secondary Structure Analysis of Protein Monolayer with Mid-Infrared Plasmonic Nanoantennas |
| Q39145449 | Recent Progress in Alzheimer's Disease Research, Part 1: Pathology |
| Q36144951 | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis |
| Q41887040 | Regulating extracellular proteostasis capacity through the unfolded protein response |
| Q26799208 | Regulation of protein homeostasis in neurodegenerative diseases: the role of coding and non-coding genes |
| Q27332087 | RepA-WH1, the agent of an amyloid proteinopathy in bacteria, builds oligomeric pores through lipid vesicles. |
| Q38845065 | Repurposing Hsp104 to Antagonize Seminal Amyloid and Counter HIV Infection. |
| Q90340275 | Retinol-Binding Protein Interferes with Transthyretin-Mediated β-Amyloid Aggregation Inhibition |
| Q104268677 | Revealing Functional Insights into ER Proteostasis through Proteomics and Interactomics |
| Q61821988 | Reversible, functional amyloids: towards an understanding of their regulation in yeast and humans |
| Q98293113 | Rhodamine-Based Metal Chelator: A Potent Inhibitor of Metal-Catalyzed Amyloid Toxicity |
| Q93112387 | Rigid helical-like assemblies from a self-aggregating tripeptide |
| Q40483316 | Role of Species-Specific Primary Structure Differences in Aβ42 Assembly and Neurotoxicity |
| Q38959892 | Role of local and nonlocal interactions in folding and misfolding of globular proteins |
| Q57292251 | SAR by kinetics for drug discovery in protein misfolding diseases |
| Q36234963 | SOD1 protein aggregates stimulate macropinocytosis in neurons to facilitate their propagation |
| Q50874930 | SODA: prediction of protein solubility from disorder and aggregation propensity. |
| Q89819024 | Salmonella Typhimurium biofilm disruption by a human antibody that binds a pan-amyloid epitope on curli |
| Q64106641 | Secondary nucleation and elongation occur at different sites on Alzheimer's amyloid-β aggregates |
| Q55713289 | Seed-Induced Heterogeneous Cross-Seeding Self-Assembly of Human and Rat Islet Polypeptides. |
| Q41074700 | Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method |
| Q41857864 | Self-assembly of a nine-residue amyloid-forming peptide fragment of SARS corona virus E-protein: mechanism of self aggregation and amyloid-inhibition of hIAPP. |
| Q57156494 | Self-assembly of functional nanostructures by short helical peptide building blocks |
| Q45326411 | Self-assembly of model proteins into virus capsids. |
| Q59350664 | Semen-derived amyloidogenic peptides-Key players of HIV infection |
| Q41109611 | Shear-Induced Amyloid Formation in the Brain: I. Potential Vascular and Parenchymal Processes |
| Q58797396 | Shear-Induced Amyloid Formation in the Brain: III. The Roles of Shear Energy and Seeding in a Proposed Shear Model |
| Q41102931 | Shear-Induced Amyloid Formation in the Brain: II. An Experimental System for Monitoring Amyloid Shear Processes and Investigating Potential Spinal Tap Problems |
| Q53826183 | Simulations and Experiments Delineate Amyloid Fibrilization by Peptides Derived from Glaucoma-Associated Myocilin. |
| Q46623825 | Simultaneous acquisition of infrared, fluorescence and light scattering spectra of proteins: direct evidence for pre-fibrillar species in amyloid fibril formation |
| Q39187447 | Single-Molecule Protein Folding Experiments Using High-Precision Optical Tweezers |
| Q92024175 | Single-residue physicochemical characteristics kinetically partition membrane protein self-assembly and aggregation |
| Q59793784 | Size-exclusion chromatography small-angle X-ray scattering of water soluble proteins on a laboratory instrument |
| Q64055973 | Spatial control of irreversible protein aggregation |
| Q47232763 | Spatiotemporal Proteomic Profiling of Huntington's Disease Inclusions Reveals Widespread Loss of Protein Function. |
| Q33719399 | Spinal motor neuron protein supersaturation patterns are associated with inclusion body formation in ALS. |
| Q39736236 | Stepwise unfolding of human β2-microglobulin into a disordered amyloidogenic precursor at low pH. |
| Q42613719 | Stilbene Boronic Acids Form a Covalent Bond with Human Transthyretin and Inhibit Its Aggregation |
| Q92192938 | Stoichiometry of Heavy Metal Binding to Peptides Involved in Alzheimer's Disease: Mass Spectrometric Evidence |
| Q37591181 | Strain-specific Fibril Propagation by an Aβ Dodecamer |
| Q64974511 | Stress-Induced Low Complexity RNA Activates Physiological Amyloidogenesis. |
| Q41711058 | Strong Electro-Optic Effect and Spontaneous Domain Formation in Self-Assembled Peptide Structures. |
| Q47591898 | Structural Dynamics of the GW182 Silencing Domain Including its RNA Recognition motif (RRM) Revealed by Hydrogen-Deuterium Exchange Mass Spectrometry |
| Q41367226 | Structural Properties of Human IAPP Dimer in Membrane Environment Studied by All-Atom Molecular Dynamics Simulations. |
| Q30831432 | Structural and fluctuational difference between two ends of Aβ amyloid fibril: MD simulations predict only one end has open conformations |
| Q89392305 | Structural and functional analysis of cystatin E reveals enzymologically relevant dimer and amyloid fibril states |
| Q38913307 | Structural and functional diversity among amyloid proteins: Agents of disease, building blocks of biology, and implications for molecular engineering |
| Q64262785 | Structural and functional impact of non-synonymous SNPs in the CST complex subunit TEN1: structural genomics approach |
| Q64076246 | Structural basis for reversible amyloids of hnRNPA1 elucidates their role in stress granule assembly |
| Q35549078 | Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formation. |
| Q55233780 | Structural modelling of the DNAJB6 oligomeric chaperone shows a peptide-binding cleft lined with conserved S/T-residues at the dimer interface. |
| Q48046294 | Structural properties of amyloid β(1-40) dimer explored by replica exchange molecular dynamics simulations. |
| Q35107359 | Structural transitions and interactions in the early stages of human glucagon amyloid fibrillation |
| Q38589790 | Structure and Dynamics of Intrinsically Disordered Proteins |
| Q36495463 | Structure-Based Derivation of Protein Folding Intermediates and Energies from Optical Tweezers |
| Q41698527 | Structured States of Disordered Proteins from Genomic Sequences |
| Q90333523 | Substituent, Charge, and Size Effects on the Fluorogenic Performance of Amyloid Ligands: A Small-Library Screening Study |
| Q36845920 | Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidoses |
| Q89421739 | Substrate relay in an Hsp70-cochaperone cascade safeguards tail-anchored membrane protein targeting |
| Q38338129 | Supersaturation is a major driving force for protein aggregation in neurodegenerative diseases |
| Q91690512 | Suppression of Mouse AApoAII Amyloidosis Progression by Daily Supplementation with Oxidative Stress Inhibitors |
| Q36175673 | Supramolecular peptide vaccines: tuning adaptive immunity |
| Q28468287 | Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer's disease |
| Q52341015 | TRIM11 activates the proteasome and promotes overall protein degradation by regulating USP14. |
| Q47123416 | Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo. |
| Q91451096 | Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy |
| Q92765544 | Tau protein aggregates inhibit the protein-folding and vesicular trafficking arms of the cellular proteostasis network |
| Q38844934 | ThT 101: a primer on the use of thioflavin T to investigate amyloid formation |
| Q90399964 | The Aggregation Conditions Define Whether EGCG is an Inhibitor or Enhancer of α-Synuclein Amyloid Fibril Formation |
| Q39071444 | The Amyloid Phenomenon and Its Links with Human Disease |
| Q91807068 | The Amyloid as a Ribbon-Like Micelle in Contrast to Spherical Micelles Represented by Globular Proteins |
| Q58486506 | The Amyloid-β Peptide in Amyloid Formation Processes: Interactions with Blood Proteins and Naturally Occurring Metal Ions |
| Q92257845 | The Effect of Proline cis-trans Isomerization on the Folding of the C-Terminal SH2 Domain from p85 |
| Q39410246 | The Endoplasmic Reticulum Unfolded Protein Response in Neurodegenerative Disorders and Its Potential Therapeutic Significance |
| Q91965550 | The Environment Is a Key Factor in Determining the Anti-Amyloid Efficacy of EGCG |
| Q33692255 | The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases |
| Q90532500 | The Insoluble Protein Deposit (IPOD) in Yeast |
| Q46302852 | The Physiological and Pathological Implications of the Formation of Hydrogels, with a Specific Focus on Amyloid Polypeptides |
| Q56978719 | The Rational Discovery of a Tau Aggregation Inhibitor |
| Q92702814 | The Role of Nrf2 in the Antioxidant Cellular Response to Medical Ozone Exposure |
| Q90227644 | The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer's Disease (AD) |
| Q58706085 | The Role of α-sheet in Amyloid Oligomer Aggregation and Toxicity |
| Q48218031 | The absence of specific yeast heat-shock proteins leads to abnormal aggregation and compromised autophagic clearance of mutant Huntingtin proteins |
| Q39004351 | The activities of amyloids from a structural perspective |
| Q50882742 | The amyloid architecture provides a scaffold for enzyme-like catalysts. |
| Q39338479 | The architecture of amyloid-like peptide fibrils revealed by X-ray scattering, diffraction and electron microscopy |
| Q34467650 | The biology of proteostasis in aging and disease |
| Q37623715 | The chaperone HSPB8 reduces the accumulation of truncated TDP-43 species in cells and protects against TDP-43-mediated toxicity. |
| Q28080017 | The contribution of intrinsically disordered regions to protein function, cellular complexity, and human disease |
| Q55071445 | The contribution of microglia to early synaptic compensatory responses that precede β-amyloid-induced neuronal death. |
| Q51066033 | The functional roles of the unstructured N- and C-terminal regions in αB-crystallin and other mammalian small heat-shock proteins. |
| Q50557388 | The heat-shock, or HSF1-mediated proteotoxic stress, response in cancer: from proteomic stability to oncogenesis. |
| Q47689801 | The molecular basis of Alzheimer's plaques. |
| Q92654685 | The molecular chaperone β-casein prevents amorphous and fibrillar aggregation of α-lactalbumin by stabilisation of dynamic disorder |
| Q90100699 | The mutational landscape of a prion-like domain |
| Q38857387 | The native state of prion protein (PrP) directly inhibits formation of PrP-amyloid fibrils in vitro |
| Q39150418 | The nucleus: keeping it together by keeping it apart. |
| Q40062947 | The physical dimensions of amyloid aggregates control their infective potential as prion particles. |
| Q41143473 | The prion-like RNA-processing protein HNRPDL forms inherently toxic amyloid-like inclusion bodies in bacteria |
| Q39437151 | The relevance of contact-independent cell-to-cell transfer of TDP-43 and SOD1 in amyotrophic lateral sclerosis |
| Q26777240 | The role of macropinocytosis in the propagation of protein aggregation associated with neurodegenerative diseases |
| Q38548820 | The route to protein aggregate superstructures: Particulates and amyloid-like spherulites. |
| Q90735772 | The same but different: the role of Hsp70 in heat shock response and prion propagation |
| Q47952877 | The wisdom of crowds: regulating cell function through condensed states of living matter. |
| Q47417959 | The β6/β7 region of the Hsp70 substrate-binding domain mediates heat-shock response and prion propagation |
| Q41921152 | Theme and variations: evolutionary diversification of the HET-s functional amyloid motif |
| Q64990456 | Theory of Sequence Effects in Amyloid Aggregation. |
| Q89934019 | Thermo- and pH-responsive fibrillization of squid suckerin A1H1 peptide |
| Q36327601 | Thermodynamic and fibril formation studies of full length immunoglobulin light chain AL-09 and its germline protein using scan rate dependent thermal unfolding |
| Q99417578 | Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors |
| Q37593610 | Thermodynamic and kinetic stability of the Josephin Domain closed arrangement: evidences from replica exchange molecular dynamics |
| Q61837209 | Thermodynamic phase diagram of amyloid-β (16-22) peptide |
| Q93000952 | Thermophoretic trap for single amyloid fibril and protein aggregation studies |
| Q64890794 | Total chemical synthesis and biophysical properties of a designed soluble 24 kDa amyloid analogue. |
| Q47425256 | Toward a Soluble Model System for the Amyloid State |
| Q89934165 | Transcriptional signature of prion-induced neurotoxicity in a Drosophila model of transmissible mammalian prion disease |
| Q36320489 | Transient misfolding dominates multidomain protein folding |
| Q52358106 | Translational Chemistry Meets Gluten-Related Disorders. |
| Q60912888 | Transthyretin Aggregation Pathway toward the Formation of Distinct Cytotoxic Oligomers |
| Q98463556 | Trodusquemine displaces protein misfolded oligomers from cell membranes and abrogates their cytotoxicity through a generic mechanism |
| Q60908258 | Trodusquemine enhances Aβ aggregation but suppresses its toxicity by displacing oligomers from cell membranes |
| Q98906844 | Tryptophan-galactosylamine conjugates inhibit and disaggregate amyloid fibrils of Aβ42 and hIAPP peptides while reducing their toxicity |
| Q58565175 | Two distinct aggregation pathways in transthyretin misfolding and amyloid formation |
| Q57401266 | Ultrasensitive Measurement of Ca2+ Influx into Lipid Vesicles Induced by Protein Aggregates |
| Q34556269 | Ultrasensitive Measurement of Ca2+ Influx into Lipid Vesicles Induced by Protein Aggregates. |
| Q51294087 | Unconventional secretion of misfolded proteins promotes adaptation to proteasome dysfunction in mammalian cells. |
| Q53109611 | Understanding Amyloid-β Oligomerization at the Molecular Level: The Role of the Fibril Surface. |
| Q46575037 | Understanding and Designing the Gold-Bio Interface: Insights from Simulations |
| Q38915018 | Understanding and predicting protein misfolding and aggregation: Insights from proteomics |
| Q91717924 | Unpacking the aggregation-oligomerization-fibrillization process of naturally-occurring hIAPP amyloid oligomers isolated directly from sera of children with obesity or diabetes mellitus |
| Q38288126 | Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids |
| Q90244501 | Unraveling the complexity of amyloid polymorphism using gold nanoparticles and cryo-EM |
| Q55222924 | Unravelling the inhibitory activity of Chlamydomonas reinhardtii sulfated polysaccharides against α-Synuclein fibrillation. |
| Q46152081 | Untangling a Repetitive Amyloid Sequence: Correlating Biofilm-Derived and Segmentally Labeled Curli Fimbriae by Solid-State NMR Spectroscopy |
| Q93048656 | Using Small-Angle Scattering Data and Parametric Machine Learning to Optimize Force Field Parameters for Intrinsically Disordered Proteins |
| Q42286231 | Using chirality to probe the conformational dynamics and assembly of intrinsically disordered amyloid proteins |
| Q90858074 | Versatile format of minichaperone-based protein fusion system |
| Q38275791 | Viral capsid assembly as a model for protein aggregation diseases: Active processes catalyzed by cellular assembly machines comprising novel drug targets |
| Q42571342 | Vitamin k3 inhibits protein aggregation: Implication in the treatment of amyloid diseases. |
| Q36147463 | W8, a new Sup35 prion strain, transmits distinctive information with a conserved assembly scheme |
| Q38731221 | Walking the tightrope: proteostasis and neurodegenerative disease |
| Q46302841 | Why are Functional Amyloids Non-Toxic in Humans? |
| Q34475749 | Widespread Proteome Remodeling and Aggregation in Aging C. elegans |
| Q42363775 | Wild type huntingtin toxicity in yeast: Implications for the role of amyloid cross-seeding in polyQ diseases. |
| Q52563556 | Zinc-coordination and C-peptide complexation: a potential mechanism for the endogenous inhibition of IAPP aggregation. |
| Q55260627 | [PIN+]ing down the mechanism of prion appearance. |
| Q35590322 | pH-induced molecular shedding drives the formation of amyloid fibril-derived oligomers |
| Q47847903 | sw ApoMb Amyloid Aggregation under Nondenaturing Conditions: The Role of Native Structure Stability |
| Q38753941 | ɑ-Synuclein strains and the variable pathologies of synucleinopathies |
| Q65002554 | α-Synuclein Aggregation Monitored by Thioflavin T Fluorescence Assay. |
| Q36499643 | α-Synuclein and huntingtin exon 1 amyloid fibrils bind laterally to the cellular membrane |
| Q47672665 | β-Amyloid and the Pathomechanisms of Alzheimer's Disease: A Comprehensive View |
| Q41117781 | β-Hairpin of Islet Amyloid Polypeptide Bound to an Aggregation Inhibitor |
Search more.